催产素
自闭症
移情
心理学
鼻腔给药
医学
临床试验
认知
社交技能
精神科
互惠(文化人类学)
临床心理学
神经科学
发展心理学
内科学
药理学
社会心理学
作者
Larry J. Young,Chris Barrett
出处
期刊:Science
[American Association for the Advancement of Science (AAAS)]
日期:2015-02-19
卷期号:347 (6224): 825-826
被引量:174
标识
DOI:10.1126/science.aaa8120
摘要
The U.S. Centers for Disease Control and Prevention estimates the prevalence of autism spectrum disorders (ASDs) to be 1 in 68 children in the United States, yet no drugs to treat the debilitating social deficits of ASD are available. Oxytocin, a natural brain peptide produced in the hypothalamus, has received considerable attention as a potential treatment for social deficits in ASD. Acute intranasal oxytocin temporarily enhances social cognition, empathy, and reciprocity in individuals with ASD (1). However, recent clinical trials have yielded mixed results, leaving the field questioning whether oxytocin can live up to the hype.
科研通智能强力驱动
Strongly Powered by AbleSci AI